Cefdinir
24 NDCs across 8 manufacturers|24 Generic,0 Brand
Cefdinir is used to treat bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 4, 1997, and the first generic was approved May 19, 2006. FDA's Orange Book lists 18 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $35 million on Cefdinir across 2.3 million claims for 1.9 million beneficiaries.
Cefdinir is available as 24 NDCs from 8 manufacturers (24 generic, 0 brand), with NADAC prices from $0.11 to $0.12 per ML — a 12% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
24
24G / 0B
Manufacturers
8
competing in market
Price Spread
$0.11 – $0.12
per ML, 16 of 24 NDCs
7d Activity
avg -1.4% WoW · of 24 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Ascend Laboratories, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cephalosporin Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing CEFDINIR
Frequently Asked Questions
What is Cefdinir used to treat?
Cefdinir is used to treat bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections and otitis media, per the National Library of Medicine's MED-RT classification.
When did Cefdinir become available as a generic?
FDA approved the first generic Cefdinir (ANDA) on May 19, 2006. The Orange Book currently lists 18 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cefdinir?
In 2024, Medicare Part D spent $35 million on Cefdinir across 2.3 million claims for 1.9 million beneficiaries.
How many Cefdinir products are on the market?
The Cefdinir drug market contains 24 NDCs from 8 manufacturers — 24 generic and 0 brand products.
What is the price range for Cefdinir?
NADAC reference prices for Cefdinir range from $0.1054 to $0.1176 per ML — a 12% difference between cheapest and most expensive. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Cefdinir?
8 manufacturers list Cefdinir in NADAC. Ranked by number of NDCs, the largest are Ascend Laboratories, LLC (5), Aurobindo Pharma Limited (5), Teva Pharmaceuticals USA Inc. (5), Lupin Pharmaceuticals Inc. (5), Sandoz Inc. (1).
How has the price of Cefdinir changed recently?
Over the past 7 days, 0 Cefdinir NDCs rose and 23 fell, with a market-wide average change of -1.4%.